The Right Time and " Pl ACE": Optimal Management of Perioperative Angiotensin-Converting Enzyme Inhibitors

被引：2
|
作者：
Chopra, Vineet [1 ,2 ]
Wijeysundera, Duminda N. [3 ,4 ,5 ]
机构：
[1] Ann Arbor VA Healthcare Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Dept Med, Ann Arbor, MI USA
[3] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[4] Toronto Gen Hosp, Dept Anesthesia, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF HOSPITAL MEDICINE | 2014年 / 9卷 / 05期
基金：
加拿大健康研究院;
关键词：
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; CLINICAL CONSEQUENCES; SYSTEM ANTAGONISTS; NONCARDIAC SURGERY; MORTALITY;
D O I：
10.1002/jhm.2203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：334 / 336
页数：3
相关论文
共 50 条
  • [1] Perioperative management of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of perioperative medicine practitioners
    Walker, Sophie L. M.
    Abbott, Tom E. F.
    Brown, Katherine
    Pearse, Rupert M.
    Ackland, Gareth L.
    PEERJ, 2018, 6
  • [2] Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit
    Vijay, A.
    Grover, A.
    Coulson, T. G.
    Myles, P. S.
    ANAESTHESIA AND INTENSIVE CARE, 2016, 44 (03) : 346 - 352
  • [3] About fACE Perioperative Use of Angiotensin-Converting Enzyme Inhibitors
    Barodka, Viachaslau
    Nyhan, Daniel
    Berkowitz, Dan
    CIRCULATION, 2012, 126 (03) : 249 - 251
  • [4] Love of Angiotensin-Converting Enzyme Inhibitors in the Time of Cholera
    Packer, Milton
    JACC-HEART FAILURE, 2016, 4 (05) : 403 - 408
  • [5] Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults
    Zou, Zui
    Yuan, Hong B.
    Yang, Bo
    Xu, Fengying
    Chen, Xiao Y.
    Liu, Guan J.
    Shi, Xue Y.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [6] Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
    Sasongko, Teguh H.
    Nagalla, Srikanth
    Ballas, Samir K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (03):
  • [7] Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
    Sasongko, Teguh H.
    Nagalla, Srikanth
    Ballas, Samir K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [8] Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
    Sasongko, Teguh Haryo
    Nagalla, Srikanth
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (12):
  • [9] Perioperative use of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists
    Vaquero Roncero, Luis Mario
    Sanchez Poveda, David
    Valdunciel Garcia, Joaquin Jose
    Sanchez Barrado, Maria Elisa
    Calvo Vecino, Jose Maria
    JOURNAL OF CLINICAL ANESTHESIA, 2017, 40 : 91 - 98
  • [10] Clinical Outcomes of Heart Failure Patients with Optimal Dose of Angiotensin-Converting Enzyme (ACE) Inhibitor
    Utomo, Y. B.
    Rohman, M. S.
    Widito, S.
    Sargowo, D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0D) : D33 - D34
12345